⌘K
Loading ticker…
As of 2026-08-24, Enovis Corporation (ENOV) has a 3-month relative strength percentile of 57 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 49. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.5%, relative volume 0.52×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
ENOV is held by 34 ETFs as of May 2026. Top owner: AVUV at 0.04% weight, $12M notional. Top 3 carry $27M.
Held by 82 ETFs · $358M across latest filings · largest weight 1.62% (ACSV).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| AVUVAvantis U.S. Small Cap Value ETF | 0.04% | $12M | new |
| FNDA | 0.09% | $8M | — |
| VTWO | 0.04% | $7M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.03% | $6M | — |
| VIOOVanguard S&P Small-Cap 600 ETF | 0.08% | $4M |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| −0.02 pp |
| VHTVanguard Health Care ETF | 0.02% | $4M | — |
| VIOVVanguard S&P Small-Cap 600 Value ETF | 0.15% | $3M | −0.04 pp |
| RWJ | 0.12% | $2M | −0.01 pp |
| AVSC | 0.07% | $2M | −0.05 pp |
| VFVA | 0.20% | $2M | +0.03 pp |
Showing 10 of 34 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ENOV Jan avg: 3.05% median: 5.92% win: 75% σ: 14.65% n: 4 2022-04-12 → 2026-07-31 | ENOV Feb avg: -2.19% median: -3.29% win: 50% σ: 14.29% n: 4 2022-04-12 → 2026-07-31 | ENOV Mar avg: -3.64% median: -4.15% win: 25% σ: 6.66% n: 4 2022-04-12 → 2026-07-31 | ENOV Apr avg: -2.85% median: -5.13% win: 40% σ: 8.63% n: 5 2022-04-12 → 2026-07-31 | ENOV May avg: -5.79% median: -8.98% win: 20% σ: 5.22% n: 5 2022-04-12 → 2026-07-31 | ENOV Jun avg: -2.82% median: -8.73% win: 40% σ: 14.97% n: 5 2022-04-12 → 2026-07-31 | ENOV Jul avg: 7.98% median: 5.40% win: 60% σ: 20.38% n: 5 2022-04-12 → 2026-07-31 | ENOV Aug avg: -3.59% median: -7.24% win: 25% σ: 13.77% n: 4 2022-04-12 → 2026-07-31 (current) | ENOV Sep avg: -6.09% median: -6.76% win: 0% σ: 3.13% n: 4 2022-04-12 → 2026-07-31 | ENOV Oct avg: -1.70% median: -0.58% win: 50% σ: 8.87% n: 4 2022-04-12 → 2026-07-31 | ENOV Nov avg: 8.10% median: 8.61% win: 75% σ: 8.77% n: 4 2022-04-12 → 2026-07-31 | ENOV Dec avg: -2.49% median: -5.61% win: 25% σ: 11.52% n: 4 2022-04-12 → 2026-07-31 |